Literature DB >> 20943633

Cancer of unknown primary site: 20 questions to be answered.

N Pavlidis1, G Pentheroudakis.   

Abstract

Cancer of unknown primary (CUP) is a common, well-recognized and heterogeneous clinical syndrome. Patients with CUP present with metastatic disease in the absence of an identifiable primary tumour despite a diagnostic work-up. Aetiologically, CUP might either harbor primaries that cannot be detected by the standardized diagnostic investigations or carry distinct genetic and epigenetic aberrations. In this article we try to clarify the clinical and pathological enigma of CUP by answering 20 important questions related to this entity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943633     DOI: 10.1093/annonc/mdq278

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  19 in total

1.  Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario.

Authors:  C S Kim; M B Hannouf; S Sarma; G B Rodrigues; P K Rogan; S M Mahmud; E Winquist; M Brackstone; G S Zaric
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

2.  The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm.

Authors:  D Kaemmerer; N Posorski; F von Eggeling; G Ernst; D Hörsch; R P Baum; V Prasad; R Langer; I Esposito; G Klöppel; S Sehner; T Knösel; M Hommann
Journal:  Clin Exp Metastasis       Date:  2014-08-07       Impact factor: 5.150

3.  Unfavorable cancers of unknown primaries: presentation and prognostic factors. A population-based 8-year experience.

Authors:  Margareta Randén; Maria Helde-Frankling; Sara Runesdotter; Peter Gunvén
Journal:  Med Oncol       Date:  2013-09-18       Impact factor: 3.064

4.  Unknown primary adenocarcinomas: a single-center experience.

Authors:  Sernaz Uzunoglu; Bulent Erdogan; Hilmi Kodaz; Ahmet Cinkaya; Esma Turkmen; Ilhan Hacibekiroglu; Ali Sari; Alaattin Ozen; Ufuk Usta; Irfan Cicin
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

5.  Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling.

Authors:  Serenus Hua; Mary Saunders; Lauren M Dimapasoc; Seung Hyup Jeong; Bum Jin Kim; Suhee Kim; Minkyung So; Kwang-Sik Lee; Jae Han Kim; Kit S Lam; Carlito B Lebrilla; Hyun Joo An
Journal:  J Proteome Res       Date:  2014-01-08       Impact factor: 4.466

6.  Classification of unknown primary tumors with a data-driven method based on a large microarray reference database.

Authors:  Kalle A Ojala; Sami K Kilpinen; Olli P Kallioniemi
Journal:  Genome Med       Date:  2011-10-17       Impact factor: 11.117

7.  Yield of esophagogastroduodenoscopy and colonoscopy in cancer of unknown primary.

Authors:  Muhammad Tayyab Usmani; Abdullah Bin Khalid; Syed Hasnain Ali Shah; Tauseef Ahmad; Saeed S Hamid; Syed M Wasim Jafri
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

8.  Extent of diagnostic inquiry among a population-based cohort of patients with cancer of unknown primary.

Authors:  Julie Smith-Gagen; Christiana M Drake; Larissa L White; Paulo S Pinheiro
Journal:  Cancer Rep Rev       Date:  2019-07-08

9.  Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities.

Authors:  D Urban; A Rao; M Bressel; Y R Lawrence; L Mileshkin
Journal:  Br J Cancer       Date:  2013-07-16       Impact factor: 7.640

10.  A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.

Authors:  Hiromichi Iwamura; Shingo Hatakeyama; Yoshimi Tanaka; Toshikazu Tanaka; Noriko Tokui; Hayato Yamamoto; Atsushi Imai; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Kazuaki Yoshikawa; Chikara Ohyama
Journal:  BMC Res Notes       Date:  2014-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.